Hcv combination therapy

Details Hcv combination therapy Hcv combination therapy

A - Human Necessities

61

K

A61K 38/21 (2006.01) A61K 31/7056 (2006.01) A61K 45/08 (2006.01) A61P 31/12 (2006.01)

Patent

CA 2306039

Methods of treating patients having susceptible viral infections, especially chronic hepatitis C infection by administering to said patient a therapeutically effective amount of a combination therapy of interferon-alfa and ribavirin for a time sufficient to lower HCV-RNA in association with a therapeutically effective amount of an antioxidant for a time sufficient to ameliorate ribavirin-related hemolysis are disclosed.

Affiliated with

Also associated with

Rating

Hcv combination therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hcv combination therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hcv combination therapy will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1341915